China Biologic Produ
(CBPO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 178,321 | 163,395 | 147,967 | 82,236 | 128,793 |
| Depreciation Amortization | 27,200 | 26,241 | 23,225 | 12,909 | 12,738 |
| Income taxes - deferred | -915 | -2,437 | -4,160 | -3,253 | -3,007 |
| Accounts receivable | -5,508 | 22,133 | -53,880 | -39,919 | -10,972 |
| Accounts payable and accrued liabilities | -2,057 | -1,299 | 8,141 | 977 | 2,967 |
| Other Working Capital | 4,380 | 13,205 | -88,276 | -23,355 | -36,322 |
| Other Operating Activity | 57,056 | 8,104 | 70,925 | 72,589 | 29,060 |
| Operating Cash Flow | $258,478 | $229,342 | $103,942 | $102,184 | $123,259 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -739,472 | 1,522,173 | 1,262,530 | N/A | N/A |
| PPE Investments | -18,904 | -19,724 | -31,619 | -37,440 | -48,978 |
| Net Acquisitions | N/A | N/A | 97,702 | N/A | 129 |
| Purchase Of Investment | -717,755 | -1,682,444 | -1,882,586 | -22,669 | N/A |
| Sale Of Investment | 1,741,262 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | -2,121 | -149 | -4,973 | -787 | -1,636 |
| Other Investing Activity | -2,121 | -150 | -4,973 | -787 | -3,671 |
| Investing Cash Flow | $263,010 | $-180,144 | $-558,945 | $-60,895 | $-52,520 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 23,009 | N/A |
| Common Stock Issued | 300 | 612 | 591,450 | 868 | 3,559 |
| Dividend Paid | -12,366 | -10,125 | -10,145 | -18,789 | -7,922 |
| Other Financing Activity | 0 | -219,957 | -10,000 | -23,412 | -17,721 |
| Financing Cash Flow | $-12,066 | $-229,470 | $571,304 | $-18,324 | $-22,084 |
| Exchange Rate Effect | 4,159 | 3,142 | 3,243 | 12,607 | -9,827 |
| Beginning Cash Position | 161,750 | 338,881 | 219,337 | 183,766 | 144,938 |
| End Cash Position | 675,332 | 161,750 | 338,881 | 219,337 | 183,766 |
| Net Cash Flow | $513,581 | $-177,130 | $119,544 | $35,571 | $38,828 |
| Free Cash Flow | |||||
| Operating Cash Flow | 258,478 | 229,342 | 103,942 | 102,184 | 123,259 |
| Capital Expenditure | -18,916 | -24,287 | -31,743 | -37,504 | -49,371 |
| Free Cash Flow | 239,562 | 205,055 | 72,199 | 64,680 | 73,887 |